Home/Filings/4/0000899243-19-012655
4//SEC Filing

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 4

Accession 0000899243-19-012655

CIK 0001300699other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 5:04 PM ET

Size

11.4 KB

Accession

0000899243-19-012655

Insider Transaction Report

Form 4
Period: 2019-05-06
Transactions
  • Purchase

    Common Stock

    2019-05-06$12.90/sh+77,010$993,4299,196,022 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2019-05-06$12.08/sh+22,990$277,7199,119,012 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Stock

    2019-05-06$12.08/sh+22,990$277,7199,119,012 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2019-05-06$12.90/sh+77,010$993,4299,196,022 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Stock

    2019-05-06$12.08/sh+22,990$277,7199,119,012 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2019-05-06$12.90/sh+77,010$993,4299,196,022 total(indirect: See Footnote)
Footnotes (3)
  • [F1]The transaction was executed in multiple trades at prices ranging from $11.50 to $12.49. The price above reflects the weighted average price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
  • [F2]The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
  • [F3]The transaction was executed in multiple trades at prices ranging from $12.50 to $13.09. The price above reflects the weighted average price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.

Issuer

Athenex, Inc.

CIK 0001300699

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001249675

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 5:04 PM ET
Size
11.4 KB